Glycated albumin and blood sugar control in advanced chronic kidney disease.
暂无分享,去创建一个
[1] T. Hasegawa,et al. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] A. Garg,et al. Hypoglycemia Incidence in Older Adults by Estimated GFR. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] C. Wanner,et al. High Glycated Albumin and Mortality in Persons with Diabetes Mellitus on Hemodialysis. , 2017, Clinical chemistry.
[4] Yuh-Feng Lin,et al. Glycated Albumin Predicts Long-term Survival in Patients Undergoing Hemodialysis , 2016, International journal of medical sciences.
[5] F. Kronenberg,et al. Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] N. Powe,et al. Serum Fructosamine and Glycated Albumin and Risk of Mortality and Clinical Outcomes in Hemodialysis Patients , 2013, Diabetes Care.
[7] B. Freedman,et al. Glycated Albumin, Not Hemoglobin A1c, Predicts Cardiovascular Hospitalization and Length of Stay in Diabetic Patients on Dialysis , 2012, American Journal of Nephrology.
[8] K. Kalantar-Zadeh. A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death , 2012, Diabetes Care.
[9] B. Freedman. A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death , 2012, Diabetes Care.
[10] K. Kalantar-Zadeh,et al. Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes , 2012, Diabetes.
[11] B. Freedman,et al. Basic Performance of an Enzymatic Method for Glycated Albumin and Reference Range Determination , 2011, Journal of diabetes science and technology.
[12] M. Rocco,et al. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[13] K. Kalantar-Zadeh,et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[14] J. Coresh,et al. Nontraditional Markers of Glycemia , 2011, Diabetes Care.
[15] Mark E. Williams,et al. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[16] B. Freedman,et al. COMPARISON OF GLYCATED ALBUMIN AND HEMOGLOBIN A1c CONCENTRATIONS IN DIABETIC SUBJECTS ON PERITONEAL AND HEMODIALYSIS , 2010, Peritoneal Dialysis International.
[17] H. Makino,et al. Glycated albumin levels predict long‐term survival in diabetic patients undergoing haemodialysis , 2008, Nephrology.
[18] B. Freedman,et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. , 2008, Kidney international.
[19] M. Inaba,et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. , 2007, Journal of the American Society of Nephrology : JASN.
[20] T. Nakao,et al. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease. , 2007, Internal medicine.
[21] Mark E. Williams,et al. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. , 2006, Kidney international.